These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37261999)

  • 21. Keampferol-3-O-rhamnoside abrogates amyloid beta toxicity by modulating monomers and remodeling oligomers and fibrils to non-toxic aggregates.
    Sharoar MG; Thapa A; Shahnawaz M; Ramasamy VS; Woo ER; Shin SY; Park IS
    J Biomed Sci; 2012 Dec; 19(1):104. PubMed ID: 23259691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of Alzheimer's amyloid-β
    Narang SS; Goyal D; Goyal B
    J Biomol Struct Dyn; 2020 Apr; 38(6):1598-1611. PubMed ID: 31046642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural basis of the 24B3 antibody against the toxic conformer of amyloid β with a turn at positions 22 and 23.
    Irie Y; Matsushima Y; Kita A; Miki K; Segawa T; Maeda M; Yanagita RC; Irie K
    Biochem Biophys Res Commun; 2022 Sep; 621():162-167. PubMed ID: 35839743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloid Fibril Formation of Arctic Amyloid-β 1-42 Peptide is Efficiently Inhibited by the BRICHOS Domain.
    Zhong X; Kumar R; Wang Y; Biverstål H; Ingeborg Jegerschöld C; J B Koeck P; Johansson J; Abelein A; Chen G
    ACS Chem Biol; 2022 Aug; 17(8):2201-2211. PubMed ID: 35876740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scrutiny of the mechanism of small molecule inhibitor preventing conformational transition of amyloid-β
    Shuaib S; Goyal B
    J Biomol Struct Dyn; 2018 Feb; 36(3):663-678. PubMed ID: 28162045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new purified Lawsoniaside remodels amyloid-β
    Dhouafli Z; Leri M; Bucciantini M; Stefani M; Gadhoumi H; Mahjoub B; Ben Jannet H; Guillard J; Tounsi MS; Ksouri R; Hayouni EA
    Int J Biol Macromol; 2018 Jul; 114():830-835. PubMed ID: 29626601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the Conformations of Amyloid Beta 42 in Solution That May Mediate Its Initial Hydrophobic Aggregation.
    Sonar K; Mancera RL
    J Phys Chem B; 2022 Oct; 126(40):7916-7933. PubMed ID: 36179370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of the toxic conformation of amyloid β42 by intramolecular disulfide bond formation.
    Matsushima Y; Yanagita RC; Irie K
    Chem Commun (Camb); 2020 Apr; 56(29):4118-4121. PubMed ID: 32163091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NMR-based site-resolved profiling of β-amyloid misfolding reveals structural transitions from pathologically relevant spherical oligomer to fibril.
    Xiao Y; Matsuda I; Inoue M; Sasahara T; Hoshi M; Ishii Y
    J Biol Chem; 2020 Jan; 295(2):458-467. PubMed ID: 31771980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the secondary structure of beta-amyloid (Abeta42) fibrils by systematic proline replacement.
    Morimoto A; Irie K; Murakami K; Masuda Y; Ohigashi H; Nagao M; Fukuda H; Shimizu T; Shirasawa T
    J Biol Chem; 2004 Dec; 279(50):52781-8. PubMed ID: 15459202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of Nucleated Conformational Conversion of Aβ42.
    Fu Z; Aucoin D; Davis J; Van Nostrand WE; Smith SO
    Biochemistry; 2015 Jul; 54(27):4197-207. PubMed ID: 26069943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic Treatment with Aβ42 with a Toxic Conformer and LPS Induces Inflammatory Responses in BV-2 Microglia with Dysregulation of Hypoxia-Inducible Factor Expression.
    Maki T; Sawahata M; Uta D; Irie K; Kume T
    Biol Pharm Bull; 2023; 46(2):359-363. PubMed ID: 36724966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Internalisation and toxicity of amyloid-β 1-42 are influenced by its conformation and assembly state rather than size.
    Vadukul DM; Maina M; Franklin H; Nardecchia A; Serpell LC; Marshall KE
    FEBS Lett; 2020 Nov; 594(21):3490-3503. PubMed ID: 32871611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth.
    McLaurin J; Franklin T; Zhang X; Deng J; Fraser PE
    Eur J Biochem; 1999 Dec; 266(3):1101-10. PubMed ID: 10583407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxic Amyloid-β42 Conformer May Accelerate the Onset of Alzheimer's Disease in the Preclinical Stage.
    Futamura A; Hieda S; Mori Y; Kasuga K; Sugimoto A; Kasai H; Kuroda T; Yano S; Tsuji M; Ikeuchi T; Irie K; Ono K
    J Alzheimers Dis; 2021; 80(2):639-646. PubMed ID: 33579852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Constructing conformational library for amyloid-β
    Dehabadi MH; Firouzi R
    J Mol Graph Model; 2022 Sep; 115():108207. PubMed ID: 35568004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Anti-Amyloidogenic Action of Doxycycline: A Molecular Dynamics Study on the Interaction with Aβ42.
    Gautieri A; Beeg M; Gobbi M; Rigoldi F; Colombo L; Salmona M
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlling amyloid-beta peptide(1-42) oligomerization and toxicity by fluorinated nanoparticles.
    Saraiva AM; Cardoso I; Pereira MC; Coelho MA; Saraiva MJ; Möhwald H; Brezesinski G
    Chembiochem; 2010 Sep; 11(13):1905-13. PubMed ID: 20661987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computational design and evaluation of β-sheet breaker peptides for destabilizing Alzheimer's amyloid-β
    Shuaib S; Narang SS; Goyal D; Goyal B
    J Cell Biochem; 2019 Oct; 120(10):17935-17950. PubMed ID: 31162715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes.
    Qiang W; Yau WM; Lu JX; Collinge J; Tycko R
    Nature; 2017 Jan; 541(7636):217-221. PubMed ID: 28052060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.